A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with advanced or recurrent non-squamous non-small cell lung cancer

被引：0
|
作者：
Yabuki, Yohei [1 ]
Otsuka, Kenji [1 ]
Ogino, Hirokazu [1 ]
Takeuchi, Eiji [2 ]
Haku, Takashi [3 ]
Kanematsu, Takanori [4 ]
Nishimura, Naoki [5 ]
Toyoda, Yuko [6 ]
Hanibuchi, Masaki [7 ]
Mitsuhashi, Atsushi [1 ]
Tsukazaki, Yuki [1 ]
Ozaki, Ryohiko [1 ]
Yoneda, Hiroto [1 ]
Nokihara, Hiroshi [1 ]
Nisihioka, Yasuhiko [1 ]
机构：
[1] Tokushima Univ Hosp, Resp Med & Rheumatol, Tokushima, Japan
[2] Natl Hosp Org Kochi Hosp, Dept Clin Invest, Kochi, Japan
[3] Tokushima Prefectural Cent Hosp, Resp Med, Tokushima, Japan
[4] Japanese Red Cross Matsuyama Hosp, Resp Med, Matsuyama, Ehime, Japan
[5] St Lukes Int Hosp, Thorac Ctr, Tokyo, Japan
[6] Japanese Red Cross Kochi Hosp, Internal Med, Kochi, Japan
[7] Shikoku Cent Hosp, Resp Med, Matsuyama, Ehime, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP08-282
引用
收藏
页码：300 / 300
页数：1
相关论文
共 50 条
  • [1] A multicenter, open-label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non-small cell lung cancer
    Yabuki, Yohei
    Hanibuchi, Masaki
    Takeuchi, Eiji
    Haku, Takashi
    Kanematsu, Takanori
    Nishimura, Naoki
    Toyoda, Yuko
    Mitsuhashi, Atsushi
    Otsuka, Kenji
    Sato, Seidai
    Goto, Hisatsugu
    Yoneda, Hiroto
    Ogino, Hirokazu
    Nokihara, Hiroshi
    Tsutomu, Shinohara
    Nishioka, Yasuhiko
    THORACIC CANCER, 2023, 14 (32) : 3232 - 3239
  • [2] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [3] Multicenter phase II study of cisplatin, pemetrexed, plus bevacizumab followed by maintenance pemetrexed plus bevacizumab for patients with advanced or recurrent non-squamous non-small cell lung cancer: MAP study
    Tsutani, Y.
    Miyata, Y.
    Masuda, T.
    Fujitaka, K.
    Doi, M.
    Awaya, Y.
    Kuyama, S.
    Kitaguchi, S.
    Ueda, K.
    Okada, M.
    ANNALS OF ONCOLOGY, 2017, 28 : 137 - 137
  • [4] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [5] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Naito, Yoshiko
    Matsuo, Norikazu
    Ishii, Hidenobu
    Tokito, Takaaki
    Azuma, Koichi
    Ichiki, Masao
    Hoshino, Tomoaki
    ANTICANCER RESEARCH, 2018, 38 (06) : 3779 - 3784
  • [7] Phase II trial of carboplatin and pemetrexed plus bevacizumab with maintenance bevacizumab as first-line treatment for elderly patients with advanced non-squamous non-small cell lung cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Ishii, Hidenobu
    Tokito, Takaaki
    Azuma, Koichi
    Naito, Yoshiko
    Matsuo, Norikazu
    Ichiki, Masao
    Hoshino, Tomoaki
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Open-label, multicenter, randomized phase II study on docetaxel plus bevacizumab or pemetrexed plus bevacizumab for treatment of elderly (aged ≥75 years) patients with previously untreated advanced non-squamous non-small cell lung cancer: TORG1323
    Kozuki, Toshiyuki
    Nogami, Naoyuki
    Hataji, Osamu
    Tsunezuka, Yoshio
    Seki, Nobuhiko
    Harada, Toshiyuki
    Fujimoto, Nobukazu
    Bessho, Akihiro
    Takamura, Kei
    Takahashi, Kazuhisa
    Satouchi, Miyako
    Kato, Terufumi
    Shukuya, Takehito
    Yamashita, Natsumi
    Okamoto, Hiroaki
    Shinkai, Tetsu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (03) : 459 - +
  • [9] Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study
    Shinoda, Masahiro
    Shinkai, Masaharu
    Hara, Yu
    Tomaru, Kouji
    Manabe, Saki
    Murakami, Syuji
    Saito, Haruhiro
    Kobayashi, Nobuaki
    Miyazawa, Naoki
    Nishikawa, Masanori
    Kaneko, Takeshi
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (06) : 486 - 494
  • [10] Open-label multicenter randomized phase II study of docetaxel plus bevacizumab or pemetrexed plus bevacizumab for elderly (≥75 years old) patients (pts) with previously untreated advanced non-squamous non-small cell lung cancer (NSCLC): TORG1323
    Honda, T.
    Kouzuki, T.
    Tsunezuka, Y.
    Seki, N.
    Shibayama, T.
    Okimoto, T.
    Taniguchi, H.
    Takeda, Y.
    Hata, N.
    Sugimoto, K.
    Takahashi, N.
    Sakai, K.
    Nishimura, T.
    Ikeda, S.
    Watanabe, S.
    Mori, K.
    Shinkai, T.
    ANNALS OF ONCOLOGY, 2018, 29 : 506 - 506
12345